O'Shaughnessy Asset Management’s Avanos Medical AVNS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-114	Closed	-$4K	–	1347
2021 Q3	$4K	Buy	114 +1	+0.9%	+$34	﹤0.01%	2359
2021 Q2	$4K	Hold	113	–	–	﹤0.01%	2170
2021 Q1	$5K	Hold	113	–	–	﹤0.01%	1910
2020 Q4	$5K	Hold	113	–	–	﹤0.01%	1657
2020 Q3	$4K	Hold	113	–	–	﹤0.01%	1509
2020 Q2	$3K	Buy	+113	New	+$3.27K	﹤0.01%	1421
2018 Q4	–	Sell	-4,005	Closed	-$273K	–	923
2018 Q3	$273K	Sell	4,005 -7,762	-66%	-$500K	0.01%	487
2018 Q2	$670K	Sell	11,767 -141	-1%	-$7.45K	0.01%	302
2018 Q1	$549K	Sell	11,908 -106	-0.9%	-$5.03K	0.01%	336
2017 Q4	$555K	Buy	12,014 +5,364	+81%	+$247K	0.01%	367
2017 Q3	$299K	Buy	+6,650	New	+$284K	0.01%	452
2015 Q3	–	Sell	-1,113	Closed	-$45K	–	893
2015 Q2	$45K	Hold	1,113	–	–	﹤0.01%	617
2015 Q1	$55K	Sell	1,113 -16	-1%	-$741	﹤0.01%	605
2014 Q4	$51K	Buy	+1,129	New	+$44.4K	﹤0.01%	643

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

O'Shaughnessy Asset Management's AVNS Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 114 shares — an estimated $4K sold.

O'Shaughnessy Asset Management first reported a position in AVNS in Q4 2014 and held it in 14 quarters. The position peaked at $670K in Q2 2018. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 114 Avanos Medical shares in Q4 2021, an estimated $4K.
O'Shaughnessy Asset Management first reported a position in Avanos Medical in Q4 2014 and held it in 14 quarters.
O'Shaughnessy Asset Management's Avanos Medical position peaked at $670K in Q2 2018.
297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.